Cargando…

Positive and negative functions of B lymphocytes in tumors

Accumulating evidence indicated that B lymphocytes exerted complex functions in tumor immunity. On the one hand, B lymphocytes can inhibit tumor development through antibody generation, antigen presentation, tumor tissue interaction, and direct killing. On the other hand, B lymphocytes have tumor-pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Meng, Sun, Qian, Wang, Jian, Pan, Wei, Ren, Xiubao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342456/ https://www.ncbi.nlm.nih.gov/pubmed/27331871 http://dx.doi.org/10.18632/oncotarget.10094

Ejemplares similares

New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
por: Shen, Meng, et al.
Publicado: (2018)

Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
por: Liu, Min, et al.
Publicado: (2020)

Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
por: Zhao, Hua, et al.
Publicado: (2021)

Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1(−)PD-L1(+) Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
por: Liu, Min, et al.
Publicado: (2021)

The role of toll-like receptor 4 in tumor microenvironment
por: Li, Jing, et al.
Publicado: (2017)

Novel strategies for cancer immunotherapy: counter-immunoediting therapy
por: Liu, Shaochuan, et al.
Publicado: (2023)

Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients
por: Chen, Ying, et al.
Publicado: (2013)

Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma
por: Zhao, Hua, et al.
Publicado: (2022)

PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection
por: Yang, Fan, et al.
Publicado: (2018)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
por: García-Teijido, Paula, et al.
Publicado: (2016)

Exhausted T cells and epigenetic status
por: Zeng, Ziqing, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
por: Luque, Melani, et al.
Publicado: (2022)

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
por: Wang, Shuhang, et al.
Publicado: (2021)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022)

PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
por: Liu, Min, et al.
Publicado: (2022)

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
por: Kuroda, Hajime, et al.
Publicado: (2021)

Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
por: Li, Man, et al.
Publicado: (2018)

BDNF expression in GISTs predicts poor prognosis when associated with PD-L1 positive tumor-infiltrating lymphocytes
por: Tian, Guang-Ang, et al.
Publicado: (2021)

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
por: Liu, Chao, et al.
Publicado: (2016)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
por: Zhong, Ying, et al.
Publicado: (2023)

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia
por: Forconi, Francesco, et al.
Publicado: (2022)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

The Roles of RUNX Proteins in Lymphocyte Function and Anti-Tumor Immunity
por: Seo, Wooseok, et al.
Publicado: (2022)

The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
por: Zhang, Lin, et al.
Publicado: (2020)

Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes
por: Wang, Jingxuan, et al.
Publicado: (2016)

T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human
por: Sun, Qian, et al.
Publicado: (2019)

T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer
por: Byun, Kyung Do, et al.
Publicado: (2018)

Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis
por: Yoshizaki, Ayumi, et al.
Publicado: (2015)

Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
por: Yu, Hongwei, et al.
Publicado: (2020)

Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia
por: Valvano, Luciana, et al.
Publicado: (2023)

Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Shen, Le-Sang, et al.
Publicado: (2020)

The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications
por: Sang, Youzhou, et al.
Publicado: (2015)

Human T lymphocytes at tumor sites
por: Notarbartolo, Samuele, et al.
Publicado: (2022)

Emotional State and Feedback-Related Negativity Induced by Positive, Negative, and Combined Reinforcement
por: Xu, Shuyuan, et al.
Publicado: (2021)

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2018)

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017)

Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4(+) T cells through regulating type 2 conventional dendritic cells
por: Luo, Jing, et al.
Publicado: (2023)

Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
por: Milardi, Giulia, et al.
Publicado: (2023)

Antioxidants: Positive or Negative Actors?
por: Salehi, Bahare, et al.
Publicado: (2018)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
por: Su, Guan-Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2b4ok26jg6dbkotqst6h3h0vl8